Harnessing Data and Technology to Strategically Change the Playing Field for Biotech
From replacement organs created by 3D bioprinting to disease-fighting medicines exquisitely tuned to specific genetic mutations, biotech offerings with the potential to dramatically improve the health and lives of patients are appearing at an ever-faster clip. Driven by digital technologies such as artificial intelligence (AI) and machine learning, as well as a torrent of data first unleashed by the mapping of the human genome 20 years ago, biotech has entered a new age of innovation. The pace of progress possible with new technologies is changing the way biotechs operate, as well as their aspirations and place in the medical ecosystem.
To read the full report, click here.